Latest Stories

Changing Diabetes

The dangers of hypoglycemia


Our digestive system breaks down carbohydrates from foods such as rice, bread, pasta, fruits and vegetables into various forms of simple sugars. One of these sugars is glucose, the body’s main source of energy.

Normal blood glucose ranges from 70 to 100 mg per deciliter (mg/dl) or 3.9 to 5.6 millimoles per liter (mmol/l). Blood glucose levels rise after a meal. Prompted by the elevated level of glucose in the bloodstream, the beta cells of the pancreas secrete the hormone insulin. Insulin facilitates the entry of glucose into the body’s cells and tissues. Any excess glucose is stored in the liver and muscles in the form of glycogen. This process lowers the level of glucose in the bloodstream and prevents it from rising to dangerously high levels (hyperglycemia). As blood glucose levels return to normal, insulin secretion by the pancreas tapers off.

In between meals, particularly during the overnight fast between dinner and breakfast, blood glucose levels drop. Any dip in blood glucose levels signals the alpha cells of the pancreas to secrete the hormone glucagon. Glucagon prompts the liver to break down stored glycogen (glycogenolysis) and release glucose back into the bloodstream. This keeps blood sugar level within a normal range until the next meal.

Aside from glycogenolysis, the body also has the ability to manufacture glucose through gluconeogenesis. Occurring primarily in the liver, this process also takes place in the kidneys and intestine. Gluconeogenesis utilizes various glucose precursors (e.g., pyruvate, lactate, glycerol, amino acids, fatty acids) to manufacture glucose and help maintain blood glucose levels within the normal range.

Hypoglycemia or abnormally low blood glucose is a condition commonly associated with the treatment of diabetes. Insulin and oral diabetes medications that increase insulin production (e.g., sulfonylureas, gliptins, meglitinides) can cause hypoglycemia. Liraglutide (brand name Victoza), a once-daily injectable medication for adults with type 2 diabetes mellitus, mimics the action of an intestinal hormone called GLP-1 that stimulates the beta cells in the pancreas to release insulin when blood sugar is too high after meals. GLP-1 also helps to lower the amount of glucose produced by the liver. It may cause hypoglycemia when taken with a sulfonylurea or insulin. Hypoglycemia may also develop if, after taking your diabetes medications, you eat less than usual (ingest less glucose) or exercise more than you normally would (use up more glucose).

Rarely, hypoglycemia can be caused by other conditions. Excessive alcohol consumption can block the liver from releasing stored glucose into the bloodstream. Severe illnesses of the liver, such as severe hepatitis, can cause hypoglycemia. A rare tumor of the pancreas called insulinoma may cause insulin overproduction resulting in hypoglycemia.

Common signs and symptoms of hypoglycemia include confusion, double/blurred vision, heart palpitations, shakiness, anxiety, sweating, hunger, and tingling sensation around the mouth. Because the primary energy source of neurons (brain cells) is glucose, hypoglycemia has a profound effect on the brain. Untreated, hypoglycemia can result in seizures, loss of consciousness, and death. Watch out for next week’s column, which will discuss ways to prevent and treat hypoglycemia.


CONTEST: Glucose is a carbohydrate. True or False? E-mail your answer to changingdiabetesph@gmail.com and get the chance to win a prize! Congratulations to Joaguin Ong! Your correct answer to the question in the September 7, 2013 column was chosen as this week’s winner in the Diabetes Trivia Contest. You will receive an e-mail on how to claim your prize.

Dr. Elizabeth Paz-Pacheco is an Associate Professor at the University of the Philippines College of Medicine and Chief of the Section of Endocrinology, Diabetes and Metabolism, UP-Philippine General Hospital. A Consultant Endocrinologist at The Medical City, she is also the editor in chief of the Journal of the Asean Federation of Endocrine Societies. The “Changing Diabetes” column commemorates the 92nd anniversary of insulin’s discovery. It aims to increase awareness on diabetes prevention, diagnosis and management. Novo Nordisk supports “Changing Diabetes.” Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. For questions or comments, e-mail changingdiabetesph@gmail.com.

Follow Us

Follow us on Facebook Follow on Twitter Follow on Twitter

Recent Stories:

Complete stories on our Digital Edition newsstand for tablets, netbooks and mobile phones; 14-issue free trial. About to step out? Get breaking alerts on your mobile.phone. Text ON INQ BREAKING to 4467, for Globe, Smart and Sun subscribers in the Philippines.

Tags: diabetes , diseases , health and wellness , hypoglycemia

Copyright © 2014, .
To subscribe to the Philippine Daily Inquirer newspaper in the Philippines, call +63 2 896-6000 for Metro Manila and Metro Cebu or email your subscription request here.
Factual errors? Contact the Philippine Daily Inquirer's day desk. Believe this article violates journalistic ethics? Contact the Inquirer's Reader's Advocate. Or write The Readers' Advocate:
c/o Philippine Daily Inquirer Chino Roces Avenue corner Yague and Mascardo Streets, Makati City, Metro Manila, Philippines Or fax nos. +63 2 8974793 to 94


  • Camilla’s brother dies in US after head injury
  • Luisita farmers storm DAR compound
  • Trillanes, Ejercito confident they are not in Napoles’ list
  • Easterlies to prevail in Luzon, Visayas
  • Lacson eyes P106-B ‘Yolanda’ rehab masterplan
  • Sports

  • Mixers trim Aces; Painters repulse Bolts
  • Donaire junks Garcia as coach, taps father
  • ’Bye Ginebra: No heavy heart this time
  • UAAP board tackles new rules
  • Baguio climb to decide Le Tour de Filipinas
  • Lifestyle

  • Photos explore dynamics of youths’ sexual identity
  • 12th Philippine Food Expo set at the World Trade Center
  • No tourist draw, Malang the croc will remain wild
  • The best flavors of summer in one bite, and more
  • Homemade yogurt, bread blended with pizza, even ramen
  • Entertainment

  • Sony developing live-action Barbie comedy
  • California court won’t review Jackson doctor case
  • Return of ‘Ibong Adarna’
  • Practical Phytos plans his future
  • In love … with acting
  • Business

  • Facebook profits triple as mobile soars
  • Insular Honors Sales Performers at Testimonial Rites
  • Apple increases stock buyback, will split stock
  • Cost-recovery provisions for affected gencos urged
  • This time, BIR goes after florists
  • Technology

  • Top Traits of Digital Marketers
  • No truth to viral no-visa ‘chronicles’
  • ‘Unlimited’ Internet promos not really limitless; lawmakers call for probe
  • Viber releases new design for iPhone, comes to Blackberry 10 for the first time
  • Engineers create a world of difference
  • Opinion

  • Editorial cartoon, April 24, 2014
  • Talking to Janet
  • Respite
  • Bucket list
  • JPII in 1981: walking a tightrope
  • Global Nation

  • Filipinos in Middle East urged to get clearance before returning
  • PH seeks ‘clearer assurance’ from US
  • China and rivals sign naval pact to ease maritime tensions
  • What Went Before: Manila bus hostage crisis
  • Obama arrives in Tokyo, first stop of 4-nation tour
  • Marketplace